Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle the early onset of various neurological diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 21, 2018 | Series Unknown | — | 1 | — | — | Detail |
May 3, 2017 | Series A | $5M | 1 | — | — | Detail |
Dec 2, 2016 | Series A | $21.50M | 1 | Takeda | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 28, 2018
StarkWare Industries
|
Series A | $30M | Blockchain | — |
Nov 13, 2017
Wellthy
|
Seed | $4.59M | Health Care | — |
Aug 21, 2017
BillionToOne
|
Seed | — | Biotechnology | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Takeda | — | Series Unknown |